Mackenzie Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2M | Buy |
101,418
+34,458
| +51% | +$18.1M | 0.07% | 220 |
|
|
2025
Q1 | $42.5M | Buy |
66,960
+11,928
| +22% | +$7.57M | 0.06% | 236 |
|
|
2024
Q4 | $39.2M | Sell |
55,032
-960
| -2% | -$684K | 0.05% | 246 |
|
|
2024
Q3 | $58.9M | Sell |
55,992
-1,972
| -3% | -$2.07M | 0.08% | 206 |
|
|
2024
Q2 | $60.9M | Buy |
57,964
+2,074
| +4% | +$2.18M | 0.09% | 184 |
|
|
2024
Q1 | $53.8M | Sell |
55,890
-395
| -0.7% | -$380K | 0.08% | 209 |
|
|
2023
Q4 | $49.4M | Sell |
56,285
-61
| -0.1% | -$53.6K | 0.07% | 213 |
|
|
2023
Q3 | $45.5M | Sell |
56,346
-3,298
| -6% | -$2.67M | 0.08% | 206 |
|
|
2023
Q2 | $42.8M | Sell |
59,644
-7,066
| -11% | -$5.07M | 0.07% | 230 |
|
|
2023
Q1 | $54.8M | Sell |
66,710
-5,239
| -7% | -$4.3M | 0.08% | 208 |
|
|
2022
Q4 | $51.9M | Sell |
71,949
-9,787
| -12% | -$7.06M | 0.09% | 197 |
|
|
2022
Q3 | $56.3M | Sell |
81,736
-7,512
| -8% | -$5.17M | 0.1% | 193 |
|
|
2022
Q2 | $52.8M | Sell |
89,248
-4,662
| -5% | -$2.76M | 0.08% | 204 |
|
|
2022
Q1 | $65.6M | Buy |
93,910
+5,702
| +6% | +$3.98M | 0.09% | 202 |
|
|
2021
Q4 | $55.7M | Sell |
88,208
-362
| -0.4% | -$229K | 0.08% | 229 |
|
|
2021
Q3 | $53.6M | Buy |
88,570
+119
| +0.1% | +$72K | 0.08% | 225 |
|
|
2021
Q2 | $49.4M | Buy |
88,451
+18,282
| +26% | +$10.2M | 0.07% | 227 |
|
|
2021
Q1 | $33.2M | Buy |
70,169
+33,297
| +90% | +$15.8M | 0.05% | 258 |
|
|
2020
Q4 | $17.8M | Buy |
36,872
+5,465
| +17% | +$2.64M | 0.04% | 268 |
|
|
2020
Q3 | $17.6M | Buy |
31,407
+8,125
| +35% | +$4.55M | 0.04% | 240 |
|
|
2020
Q2 | $14.5M | Buy |
23,282
+4,521
| +24% | +$2.82M | 0.04% | 260 |
|
|
2020
Q1 | $9.16M | Buy |
18,761
+593
| +3% | +$290K | 0.03% | 284 |
|
|
2019
Q4 | $6.82M | Buy |
18,168
+14,722
| +427% | +$5.53M | 0.02% | 384 |
|
|
2019
Q3 | $956K | Buy |
3,446
+2,485
| +259% | +$689K | ﹤0.01% | 726 |
|
|
2019
Q2 | $301K | Sell |
961
-5,851
| -86% | -$1.83M | ﹤0.01% | 957 |
|
|
2019
Q1 | $2.8M | Buy |
6,812
+5,308
| +353% | +$2.18M | 0.01% | 697 |
|
|
2018
Q4 | $562K | Sell |
1,504
-4
| -0.3% | -$1.5K | ﹤0.01% | 917 |
|
|
2018
Q3 | $609K | Buy |
1,508
+225
| +18% | +$90.9K | ﹤0.01% | 836 |
|
|
2018
Q2 | $443K | Buy |
1,283
+271
| +27% | +$93.6K | ﹤0.01% | 810 |
|
|
2018
Q1 | $348K | Buy |
1,012
+469
| +86% | +$161K | ﹤0.01% | 784 |
|
|
2017
Q4 | $204K | Buy |
+543
| New | +$204K | ﹤0.01% | 794 |
|